Stay updated on GTX-102 Safety in Angelman Syndrome Kids Clinical Trial

Sign up to get notified when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T13:52:26.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-12T14:49:53.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The history view now displays the latest revision as v3.7.0, replacing the previous v3.6.6 in the revision list. This indicates an update to the record's metadata rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-09-21T20:52:01.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page history now displays Revision: v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-31T16:19:55.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 is added to the history. The previous revision v3.6.4 is removed.
    Difference
    0.1%
    Check dated 2026-08-10T10:42:12.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.4, was added to the history, replacing the previous v3.6.3 entry.
    Difference
    0.1%
    Check dated 2026-07-27T05:47:05.000Z thumbnail image

Stay in the know with updates to GTX-102 Safety in Angelman Syndrome Kids Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.